Yellowstone aims to unlock a new class of therapeutically targetable frequently expressed antigens with potential to significantly transform patient lives.

Spun out of the University of Oxford, Yellowstone is built around the pioneering research of Professor Paresh Vyas, a world-renowned scientific academic, key opinion leader and practising clinician with a specialist focus on acute myeloid leukaemia (AML).

The Company is headquartered in Oxford, UK, with backing from a leading FTSE 250 healthcare company, Syncona.

Biotechnology

Health Care

Life Sciences

Research

Therapeutics

Yellowstone Biosciences

Yellowstone Biosciences' headquarters in Oxford, United Kingdom

Description

People (2)

Julian Hirst

Chris Hollowood

Jobs